PMID- 14615370 OWN - NLM STAT- MEDLINE DCOM- 20040415 LR - 20210206 IS - 0006-4971 (Print) IS - 0006-4971 (Linking) VI - 103 IP - 6 DP - 2004 Mar 15 TI - A critical role for CCR2/MCP-1 interactions in the development of idiopathic pneumonia syndrome after allogeneic bone marrow transplantation. PG - 2417-26 AB - Idiopathic pneumonia syndrome (IPS) is a major complication after allogeneic bone marrow transplantation (allo-BMT) and involves the infiltration of donor leukocytes and the secretion of inflammatory cytokines. We hypothesized that leukocyte recruitment during IPS is dependent in part upon interactions between chemokine receptor 2 (CCR2) and its primary ligand monocyte chemoattractant protein-1 (MCP-1). To test this hypothesis, IPS was induced in a lethally irradiated parent --> F1 mouse BMT model. Compared with syngeneic controls, pulmonary expression of MCP-1 and CCR2 mRNA was significantly increased after allo-BMT. Transplantation of CCR2-deficient (CCR2-/-) donor cells resulted in a significant reduction in IPS severity compared with transplantation of wild-type (CCR2+/+) cells and in reduced bronchoalveolar lavage (BAL) fluid cellularity and BAL fluid levels of tumor necrosis factor-alpha (TNF-alpha) and soluble p55 TNF receptor (sTNFRI). In addition, neutralization of MCP-1 resulted in significantly decreased lung injury compared with control-treated allogeneic recipients. Experimental data correlated with preliminary clinical findings; patients with IPS have elevated levels of MCP-1 in the BAL fluid at the time of diagnosis. Collectively, these data demonstrate that CCR2/MCP-1 interactions significantly contribute to the development of experimental IPS and suggest that interventions blocking these receptor-ligand interactions may represent novel strategies to prevent or treat this lethal complication after allo-BMT. FAU - Hildebrandt, Gerhard C AU - Hildebrandt GC AD - Department of Internal Medicine, University of Michigan, Ann Arbor, 48109, USA. FAU - Duffner, Ulrich A AU - Duffner UA FAU - Olkiewicz, Krystyna M AU - Olkiewicz KM FAU - Corrion, Leigh A AU - Corrion LA FAU - Willmarth, Nicole E AU - Willmarth NE FAU - Williams, Debra L AU - Williams DL FAU - Clouthier, Shawn G AU - Clouthier SG FAU - Hogaboam, Cory M AU - Hogaboam CM FAU - Reddy, Pavan R AU - Reddy PR FAU - Moore, Bethany B AU - Moore BB FAU - Kuziel, William A AU - Kuziel WA FAU - Liu, Chen AU - Liu C FAU - Yanik, Gregory AU - Yanik G FAU - Cooke, Kenneth R AU - Cooke KR LA - eng GR - 5K12HD028820-12/HD/NICHD NIH HHS/United States GR - R01-HL072258-01/HL/NHLBI NIH HHS/United States PT - Journal Article PT - Research Support, Non-U.S. Gov't PT - Research Support, U.S. Gov't, Non-P.H.S. PT - Research Support, U.S. Gov't, P.H.S. DEP - 20031113 PL - United States TA - Blood JT - Blood JID - 7603509 RN - 0 (Ccr2 protein, mouse) RN - 0 (Chemokine CCL2) RN - 0 (Cytokines) RN - 0 (RNA, Messenger) RN - 0 (Receptors, CCR2) RN - 0 (Receptors, Chemokine) SB - IM MH - Animals MH - Bone Marrow Transplantation/*adverse effects MH - Bronchoalveolar Lavage Fluid/cytology/immunology MH - Chemokine CCL2/*metabolism MH - Cytokines/metabolism MH - Female MH - Lung/immunology/pathology MH - Macrophages/immunology/pathology MH - Mice MH - Mice, Inbred C57BL MH - Mice, Mutant Strains MH - Monocytes/immunology/pathology MH - Pneumonia/*immunology/*metabolism/pathology MH - RNA, Messenger/metabolism MH - Receptors, CCR2 MH - Receptors, Chemokine/genetics/*metabolism MH - Severity of Illness Index MH - T-Lymphocytes/immunology/pathology MH - Transplantation, Homologous EDAT- 2003/11/15 05:00 MHDA- 2004/04/16 05:00 CRDT- 2003/11/15 05:00 PHST- 2003/11/15 05:00 [pubmed] PHST- 2004/04/16 05:00 [medline] PHST- 2003/11/15 05:00 [entrez] AID - S0006-4971(20)50045-1 [pii] AID - 10.1182/blood-2003-08-2708 [doi] PST - ppublish SO - Blood. 2004 Mar 15;103(6):2417-26. doi: 10.1182/blood-2003-08-2708. Epub 2003 Nov 13.